首页 > 市场调查报告书 > 医疗设备

药物递输设备

北美输液设备市场规模和预测、区域份额、趋势和成长机会分析报告范围：按产品类型、应用、最终用户和国家/地区

市场调查报告书

商品编码

1558388

北美输液设备市场规模和预测、区域份额、趋势和成长机会分析报告范围：按产品类型、应用、最终用户和国家/地区

North America Infusion Devices Market Size and Forecast, Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Application, End User, and Country

出版日期: 2024年08月30日 | 出版商:

The Insight Partners | 英文 109 Pages | 订单完成后即时交付

价格

简介目录图表

北美输液设备市场规模预计将从 2023 年的 54.9415 亿美元增至 2031 年的 91.1647 亿美元。

根据美国人口普查局的数据，65岁及以上的美国人数量预计将从2022年的5,800万增加到2050年的8,200万，增幅为47%。此外，65 岁及以上年龄组占总人口的比例预计将从 17% 上升至 23%。根据加拿大统计局的数据，到 2022 年，近 18.8% 的加拿大人年龄为 65 岁。近 20% 的加拿大人口年龄在 65 岁及以上。此外，人口预测表明，到 2068 年，21% 至 29% 的加拿大人可能会达到 65 岁或以上。

以下列出了对老年人进行输液治疗的一些主要好处。

补液和电解质平衡：由于口渴减少、某些药物和肾功能变化等因素，老年人脱水的风险可能更高。静脉输液可以帮助老年人维持整体健康所需的水分和电解质水平。

营养支持与改善：老化使人体更难摄取正确的营养，增加罹患慢性病的风险。输液疗法为老年人提供了一种有效获取必需矿物质、维生素和氨基酸的直接方法。

增强免疫功能：老年人的免疫系统可能需要额外的支持，因为他们更容易受到感染。输液疗法可以将维生素 C、锌和谷胱甘肽等增强免疫力的营养素直接输送到身体。

疼痛管理：许多老年人每天都要面对慢性疼痛，影响他们的生活品质。输液疗法可以透过将药物直接输送到血液中来快速有效地控制疼痛，从而缓解疼痛并减少发炎。

因此，不断增加的老年人口推动了北美地区对输液设备的需求。

市场参与者的策略性倡议

不同的市场参与者专注于策略发展，例如产品发布、合併、收购和合作，以开发先进的产品，帮助缓解糖尿病、癌症、慢性疼痛等慢性疾病的治疗。以下是北美输液设备市场的一些最新发展。

2024 年 4 月，Mackenzie Health 在加拿大推出了一项技术，允许静脉 (IV) 药物帮浦和病患电子病历之间进行双向资讯流。该技术称为 BD Alaris EMR Interoperability，无需医疗保健专业人员对泵浦进行手动编程。它将输液安全资讯传送回 Epic EMR，从而降低管理错误的风险并在 EMR 中提供准确的输液记录。

2022年11月，美敦力公司宣布在美国推出美敦力扩展输液器。它是第一款也是唯一一款标有可穿戴长达 7 天的输液器。输液器是将胰岛素从胰岛素帮浦输送到体内的管道，通常需要每两到三天更换一次。

2022 年 5 月，Fresenius Kabi 收购了 Ivenix 及其先进的输液泵技术，扩大了其先进输液泵和医疗保健专业人员解决方案的产品组合，以满足整个护理过程中的医疗保健需求。费森尤斯卡比也宣布，该公司已迅速扩大在美国的输液治疗产品组合，多种静脉注射解决方案获得 FDA 批准，预计其北卡罗来纳州生产基地有资格向美国客户提供静脉注射解决方案。

2022 年 3 月，Fresenius Kabi 的无线 Agilia Connect 输液系统获得 FDA 510(k) 监管许可。该系统包括 Agilia 容量泵和 Agilia 注射泵，采用 Vigilant 软体套件 - Vigilant Master Med 技术。这两款泵都是首批按照 TIR101 标准获得批准的泵，该标准由医疗器材促进协会 (AAMI) 于 2021 年制定。

产品批准、发布和策略合作数量的激增可能为未来的输液设备市场创造利润丰厚的机会。

基于最终用户的见解

根据最终用户，北美输液设备市场分为医院和专科诊所、家庭护理机构、门诊手术中心等。医院和专科诊所细分市场在 2023 年占据主导地位。医院和诊所是患者完成诊断并选择治疗方案和替代方案的主要接触点。医院和诊所的现有基础设施可以为患有任何疾病的患者提供高品质的护理，因为他们可以获得先进的医疗设备。医院和诊所预计将占据相当大的市场份额，因为新兴国家和已开发国家的大多数患者更喜欢去医院解决健康相关问题。

由于输液帮浦具有精确度、准确度和易用性等额外优点，输液帮浦在医院和诊所得到了大规模使用。这些帮浦可用于化疗、疼痛管理和糖尿病管理等应用，这些是患者住院时间较长或较短的主要原因。

WellSpan Health 和 BD 公司 CareFusion 共同宣布在所有四家 WellSpan 医院实施 Alaris 系统。 WellSpan 约克医院是第一家启用新型输液设备以及电子健康记录和输液设备之间双向互通性的医院。

因此，输液帮浦的优点和多种应用推动了北美医院和诊所输液设备市场的成长。

根据应用，市场分为糖尿病、肿瘤学、疼痛管理、血液学、儿科、胃肠病学等。 2023 年，糖尿病细分市场占据最大市场份额，预计 2023-2031 年期间复合年增长率最高。

根据最终用户，北美输液设备市场分为医院和专科诊所、家庭护理机构、门诊手术中心等。医院和专科诊所细分市场在 2023 年占据主导地位。

According to the US Census Bureau, the number of Americans aged 65 and above is expected to rise from 58 million in 2022 to 82 million by 2050, which is a 47% increase. Additionally, the share of the total population for the 65-and-older age group is projected to rise from 17% to 23%. According to Statistics Canada, in 2022, almost ~18.8% of Canadians were aged 65 years. Almost 20% of the Canadian population is aged 65 years and above. Furthermore, population projections suggest that 21% to 29% of Canadians could be aged 65 or above by 2068.

A few key benefits of infusion therapy administered in senior populations are listed below.

Rehydration and electrolyte balance: Dehydration can be a higher risk for seniors due to factors such as decreased thirst, certain medications, and changes in kidney function. IV fluids can help seniors maintain the necessary hydration and electrolyte levels for overall health.

Nutrition support and improvement: Aging makes it harder for human bodies to consume the right nutrients, increasing the risk of chronic illnesses. Infusion therapy provides a direct way for seniors to get essential minerals, vitamins, and amino acids efficiently.

Immune function reinforcement: Immune systems of elderly people may need extra support, as they are more vulnerable to infections. Infusion therapy can deliver immune-boosting nutrients such as vitamin C, zinc, and glutathione directly to the body.

Pain management: Many seniors deal with chronic pain daily, affecting their quality of life. Infusion therapy can quickly and effectively manage pain by delivering medication directly into the bloodstream, providing relief and reducing inflammation.

Thus, the increasing geriatric population drives the demand for infusion devices across North America.

Strategic Initiatives by Market Players

Various market players focus on strategic developments such as product launches, mergers, acquisitions, and collaborations to develop advanced products that help ease the treatment of chronic disorders such as diabetes, cancer, chronic pain among others. Following are a few recent developments in the North America infusion devices market.

In April 2024, Mackenzie Health launched a technology in Canada that allows for two-way information flow between an intravenous (IV) medication pump and a patient's electronic medical record. The technology, known as BD Alaris EMR Interoperability, eliminates the need for healthcare professionals to manually program pumps. It sends infusion safety information back to Epic EMR, reducing the risk of administration errors and providing an accurate infusion record in the EMR.

In November 2022, Medtronic plc announced the launch of Medtronic Extended infusion set in the US. It is the first and only infusion set labeled for up to seven-day wear. An infusion set is tubing that delivers insulin from an insulin pump to the body and usually needs to be changed every two to three days.

In May 2022, Fresenius Kabi acquired Ivenix and its advanced infusion pump technology, expanding its portfolio of advanced infusion pumps and solutions for healthcare professionals to address healthcare needs across the care continuum. Fresenius Kabi also announced that it has rapidly expanded its infusion therapy portfolio in the US, obtaining FDA approvals for multiple IV solutions in anticipation of qualifying its North Carolina manufacturing site to supply the US customers with IV solutions.

In March 2022, Fresenius Kabi received 510(k) regulatory clearance from the FDA for its wireless Agilia Connect Infusion System. The system includes the Agilia Volumetric Pump and the Agilia Syringe Pump with Vigilant Software Suite-Vigilant Master Med technology. Both pumps are the first to be cleared following TIR101 standards, which were developed by the Association for the Advancement of Medical Instrumentation (AAMI) in 2021.

An upsurge in the number of product approvals, launches, and strategic collaborations is likely to create lucrative opportunities for the infusion devices market in the future.

End User-Based Insights

Based on end user, the North America infusion devices market is divided into hospitals and specialty clinics, homecare settings, ambulatory surgical centers, and others. The hospitals and specialty clinics segment dominated the market in 2023. The homecare settings segment is anticipated to register the highest CAGR during 2023-2031. Hospitals and clinics are primary contact points for patients to get their diagnosis done and opt for treatment options and alternatives. Available infrastructure in hospitals and clinics can provide high-quality care for patients suffering from any disease condition as they have access to advanced medical devices. The hospitals and clinics segment is projected to hold a considerable market share as a majority of patients in emerging nations and developed countries prefer visiting hospitals for health-related problems.

Infusion pumps are being used on a large scale in hospitals and clinics, owing to the additional benefits offered by the pumps such as precision, accuracy, and ease of use. The pumps can be used for applications such as chemotherapy, pain management, and diabetes management, which are the major reasons for patients being admitted for longer and shorter duration.

WellSpan Health and CareFusion, a BD company, jointly announced the implementation of the Alaris System across all four WellSpan hospitals. WellSpan York Hospital is the first hospital to go live with new infusion devices and bi-directional interoperability between the electronic health record and infusion device.

Hence, the benefits and the multiple applications of infusion pumps fuel the North America infusion devices market growth for the hospitals and clinics segment.

By application, the market is segmented into diabetes, oncology, pain management, hematology, pediatrics, gastroenterology, and others. The diabetes segment held the largest share of the market in 2023, and it is projected to register the highest CAGR in the market during 2023-2031.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. North America Infusion Devices Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Overview of Mainstream System for infusion Pumps by US
- 4.3.1 Syringe Infusion Pumps:
- 4.3.2 Volumetric Infusion Pumps:
4.4 List of Best-Selling infusion Pumps along with the Model Number

5. North America Infusion Devices Market - Key Market Dynamics

5.1 North America Infusion Devices Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increasing Prevalence of Cancer
- 5.2.2 Growing Geriatric Population
5.3 Market Restraints
- 5.3.1 Frequent Product Recalls of Infusion Devices
5.4 Market Opportunities
- 5.4.1 Strategic Initiatives by Market Players
5.5 Future Trends
- 5.5.1 Growing Technological Advancements
5.6 Impact of Drivers and Restraints:

6. North America Infusion Devices Market Analysis

6.1 North America Infusion Devices Market Revenue (US$ Million), 2021-2031
6.2 North America Infusion Devices Market Forecast and Analysis

7. North America Infusion Devices Market Analysis - by Product Type

7.1 Infusion Pumps
- 7.1.1 Overview
- 7.1.2 Infusion Pumps: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Infusion Sets
- 7.2.1 Overview
- 7.2.2 Infusion Sets: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)

8. North America Infusion Devices Market Analysis - by Application

8.1 Diabetes
- 8.1.1 Overview
- 8.1.2 Diabetes: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Oncology
- 8.2.1 Overview
- 8.2.2 Oncology: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Pain Management
- 8.3.1 Overview
- 8.3.2 Pain Management: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Hematology
- 8.4.1 Overview
- 8.4.2 Hematology: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Pediatrics
- 8.5.1 Overview
- 8.5.2 Pediatrics: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
8.6 Gastroenterology
- 8.6.1 Overview
- 8.6.2 Gastroenterology: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)

9. North America Infusion Devices Market Analysis - by End User

9.1 Hospitals and Specialty Clinics
- 9.1.1 Overview
- 9.1.2 Hospitals and Specialty Clinics: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Homecare Settings
- 9.2.1 Overview
- 9.2.2 Homecare Settings: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Ambulatory Surgical Centers
- 9.3.1 Overview
- 9.3.2 Ambulatory Surgical Centers: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Others
- 9.4.1 Overview
- 9.4.2 Others: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)

10. North America Infusion Devices Market - Country Analysis

10.1 North America
- 10.1.1 North America Infusion Devices Market Breakdown by Countries
- 10.1.2 North America Infusion Devices Market Revenue and Forecast and Analysis - by Country
  - 10.1.2.1 North America Infusion Devices Market Revenue and Forecast and Analysis - by Country
  - 10.1.2.2 United States: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.2.1 United States: North America Infusion Devices Market Breakdown by Product Type
    - 10.1.2.2.2 United States: North America Infusion Devices Market Breakdown by Infusion Pumps
    - 10.1.2.2.3 United States: North America Infusion Devices Market Breakdown by Infusion Sets
    - 10.1.2.2.4 United States: North America Infusion Devices Market Breakdown by Application
    - 10.1.2.2.5 United States: North America Infusion Devices Market Breakdown by End User
  - 10.1.2.3 Canada: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.3.1 Canada: North America Infusion Devices Market Breakdown by Product Type
    - 10.1.2.3.2 Canada: North America Infusion Devices Market Breakdown by Infusion Pumps
    - 10.1.2.3.3 Canada: North America Infusion Devices Market Breakdown by Infusion Sets
    - 10.1.2.3.4 Canada: North America Infusion Devices Market Breakdown by Application
    - 10.1.2.3.5 Canada: North America Infusion Devices Market Breakdown by End User
  - 10.1.2.4 Mexico: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.4.1 Mexico: North America Infusion Devices Market Breakdown by Product Type
    - 10.1.2.4.2 Mexico: North America Infusion Devices Market Breakdown by Infusion Pumps
    - 10.1.2.4.3 Mexico: North America Infusion Devices Market Breakdown by Infusion Sets
    - 10.1.2.4.4 Mexico: North America Infusion Devices Market Breakdown by Application
    - 10.1.2.4.5 Mexico: North America Infusion Devices Market Breakdown by End User

11. North America Infusion Devices Market - Industry Landscape

11.1 Overview
11.2 Growth Strategies in North America Infusion Devices Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview
11.5 Company Positioning:

12. Company Profiles

12.1 Becton Dickinson and Co
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Fresenius Kabi AG
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 B Braun SE
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 CODAN US Corp
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Baxter International Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Elimedical Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 ICU Medical Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 BPL Medical Technologies Pvt Ltd
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Nipro Corp
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 KD Scientific Inc
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
12.11 Medtronic Plc
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments
12.12 Zimed Healthcare Ltd
- 12.12.1 Key Facts
- 12.12.2 Business Description
- 12.12.3 Products and Services
- 12.12.4 Financial Overview
- 12.12.5 SWOT Analysis
- 12.12.6 Key Developments
12.13 Terumo Corp
- 12.13.1 Key Facts
- 12.13.2 Business Description
- 12.13.3 Products and Services
- 12.13.4 Financial Overview
- 12.13.5 SWOT Analysis
- 12.13.6 Key Developments
12.14 Eitan Medical Ltd
- 12.14.1 Key Facts
- 12.14.2 Business Description
- 12.14.3 Products and Services
- 12.14.4 Financial Overview
- 12.14.5 SWOT Analysis
- 12.14.6 Key Developments
12.15 Polymedicure
- 12.15.1 Key Facts
- 12.15.2 Business Description
- 12.15.3 Products and Services
- 12.15.4 Financial Overview
- 12.15.5 SWOT Analysis
- 12.15.6 Key Developments
12.16 Moog Inc
- 12.16.1 Key Facts
- 12.16.2 Business Description
- 12.16.3 Products and Services
- 12.16.4 Financial Overview
- 12.16.5 SWOT Analysis
- 12.16.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. North America Infusion Devices Market Segmentation
Table 2. North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
Table 3. North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
Table 4. North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 5. North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 6. North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by Country
Table 7. United States: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
Table 8. United States: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by Infusion Pumps
Table 9. United States: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by Infusion Sets
Table 10. United States: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 11. United States: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 12. Canada: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
Table 13. Canada: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by Infusion Pumps
Table 14. Canada: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by Infusion Sets
Table 15. Canada: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 16. Canada: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 17. Mexico: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
Table 18. Mexico: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by Infusion Pumps
Table 19. Mexico: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by Infusion Sets
Table 20. Mexico: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 21. Mexico: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 22. Recent Organic Growth Strategies in North America Infusion Devices Market
Table 23. Recent Inorganic Growth Strategies in the North America Infusion Devices Market
Table 24. Glossary of Terms, North America Infusion Devices Market

List Of Figures

Figure 1. North America Infusion Devices Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Estimated Number of New Cancer Cases, US, 2024
Figure 4. Statistics of Incidence of Cancer at Glance, Canada, 2022
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. North America Infusion Devices Market Revenue (US$ Million), 2021-2031
Figure 7. North America Infusion Devices Market Share (%) - by Product Type, 2023 and 2031
Figure 8. Infusion Pumps: North America Infusion Devices Market- Revenue and Forecast to 2031 (US$ Million)
Figure 9. Infusion Sets: North America Infusion Devices Market- Revenue and Forecast to 2031 (US$ Million)
Figure 10. North America Infusion Devices Market Share (%) - by Application, 2023 and 2031
Figure 11. Diabetes: North America Infusion Devices Market- Revenue and Forecast to 2031 (US$ Million)
Figure 12. Oncology: North America Infusion Devices Market- Revenue and Forecast to 2031 (US$ Million)
Figure 13. Pain Management: North America Infusion Devices Market- Revenue and Forecast to 2031 (US$ Million)
Figure 14. Hematology: North America Infusion Devices Market- Revenue and Forecast to 2031 (US$ Million)
Figure 15. Pediatrics: North America Infusion Devices Market- Revenue and Forecast to 2031 (US$ Million)
Figure 16. Gastroenterology: North America Infusion Devices Market- Revenue and Forecast to 2031 (US$ Million)
Figure 17. Others: North America Infusion Devices Market- Revenue and Forecast to 2031 (US$ Million)
Figure 18. North America Infusion Devices Market Share (%) - by End User, 2023 and 2031
Figure 19. Hospitals and Specialty Clinics: North America Infusion Devices Market- Revenue and Forecast to 2031 (US$ Million)
Figure 20. Homecare Settings: North America Infusion Devices Market- Revenue and Forecast to 2031 (US$ Million)
Figure 21. Ambulatory Surgical Centers: North America Infusion Devices Market- Revenue and Forecast to 2031 (US$ Million)
Figure 22. Others: North America Infusion Devices Market- Revenue and Forecast to 2031 (US$ Million)
Figure 23. North America Infusion Devices Market Breakdown by Key Countries, 2023 and 2031 (%)
Figure 24. United States: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
Figure 25. Canada: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
Figure 26. Mexico: North America Infusion Devices Market - Revenue and Forecast to 2031 (US$ Million)
Figure 27. Growth Strategies in North America Infusion Devices Market